Loading...
Disc Medicine, Inc.
IRON•NASDAQ
Healthcare
Biotechnology
$60.61
$0.03(0.05%)
Disc Medicine, Inc. (IRON) Company Profile & Overview
Explore Disc Medicine, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Disc Medicine, Inc. (IRON) Company Profile & Overview
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
SectorHealthcare
IndustryBiotechnology
CEOJohn D. Quisel
Contact Information
Company Facts
94 Employees
IPO DateAug 12, 2020
CountryUS
Actively Trading